FDA Approves COVID-19 Vaccine for Babies Amid Summer Surge

Aug 29, 2024, 06:54 PM

The U.S. Food and Drug Administration (FDA) has approved a new COVID-19 vaccine for emergency use, targeting babies as young as six months old, despite unsupported claims of its efficacy and in the absence of an emergency. This approval comes amidst a summer surge in COVID-19 infections across the United States, with cases rising notably in regions such as the D.C. area. Despite the increase in infections, COVID-associated deaths remain at low levels compared to previous years. The new vaccine aims to address the latest variants, although its efficacy in reducing hospitalizations and deaths is debated. As the surge continues, discussions are emerging about potentially returning to pandemic measures seen in 2020.